等待开盘 04-02 09:30:00 美东时间
-0.070
-0.59%
今日重点评级关注:HC Wainwright & Co.:维持NovoCure"买入"评级,目标价从47美元升至49美元;Citizens:维持Ironwood医药"跑赢大市"评级,目标价从8美元升至10美元
02-27 11:07
Leerink Partners analyst Whit Mayo maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the price target from $13 to $12.
02-27 03:33
Halper Sadeh Probes AdaptHealth Directors for Fiduciary Breaches Halper Sadeh LLC is investigating whether certain officers and directors of AdaptHealth Corp. breached their fiduciary duties to shareholders. The firm urged long-term shareholders to contact it to discuss potential claims and possible
02-26 08:59
AdaptHealth shares are trading lower after the company reported worse-than-expe...
02-25 00:43
AdaptHealth (NASDAQ:AHCO) just disclosed its Q4 earnings on Tuesday, February 2...
02-24 20:28
The Q4 earnings report for AdaptHealth (NASDAQ:AHCO) was released on Tuesday, F...
02-24 20:22
AdaptHealth (NASDAQ:AHCO) reported quarterly earnings of $0.19 per share which missed the analyst consensus estimate of $0.35 by 45.71 percent. This is a 44.12 percent decrease over earnings of $0.34 per share from the
02-24 20:20
AdaptHealth Q4 revenue beats expectations, loss bigger than expected Overview Healthcare-at-home provider's Q4 revenue beat analyst expectations Q4 operating loss and pretax loss wider than analyst expectations Company expanded footprint by acquiring HME provider in Hawaii Outlook AdaptHealth foreca
02-24 20:14
Guidance for Fiscal Year 2026While fourth quarter 2025 Adjusted EBITDA was impacted by a legal settlement expense of $14.5 million and over $10 million of strategic investments to accelerate onboarding the new capitated
02-24 20:07
Companies Reporting Before The Bell • China Yuchai Intl (NYSE:CYD) is expected ...
02-24 19:11